Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
GC

GREG CHESMORE

Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
Madison, WI · current

The past 12 months

Clients
3
past 12 months
Filings
6
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATE

Specific issues

Issues related to patient access to innovative therapies,H.R. 4709 - Newborn Screening Saves Lives Reauthorization, H.R. 7118 - Genomic Answers for Children's Health
Health Issues · 2026 Q2
Issues related to patient access to innovative therapies, H.R. 7871 - MVP Act, H.R. 5187 - Sickle Cell Disease, H.R. 7837 - Most Favored Nation Drug Pricing
Health Issues · 2026 Q2
Issues related to patient access to innovative therapies, H.R. 5187 - Sickle Cell Disease H.R. 5094 - Orphan Drugs
Health Issues · 2026 Q2
Issues related to patient access to innovative therapies
Health Issues · 2026 Q2

Clients

2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings6
2026 Q2
BEAM THERAPEUTICS
Q2lda.gov →
2026 Q2
BEREN THERAPEUTICS
Q2lda.gov →
2026 Q2
AGIOS PHARMACEUTICALS
Q2lda.gov →
2026 Q2
BEAM THERAPEUTICS
RRlda.gov →
2026 Q2
AGIOS PHARMACEUTICALS
RRlda.gov →
2026 Q2
BEREN THERAPEUTICS
RRlda.gov →